SCHEMBL25074009

SCHEMBL25074009

CN1CC[C@H](CN2CCNCC2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
GBA1 P04062 1/20 0.38
CNR1 P21554 1/20 0.37
RAD52 P43351 1/20 0.37
GNAO1 P09471 4/20 0.37
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CHRM5 P08912 1/20 0.34
ADRA2C P18825 1/20 0.34
CXCR4 P61073 2/20 0.34
ACHE P22303 1/20 0.34
CACNA2D1 P54289 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNB1 Q02641 1/20 0.33
CACNA1C Q13936 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18883293 1.00 NCF1 (0.39) NCF1CYP1A2CYP2D6GBA1CNR1
SCHEMBL23874494 0.96 ACHE (0.40) NCF1CYP1A2CYP2D6GBA1CNR1
SCHEMBL21094260 0.94 RAD52 (0.38) NCF1CYP1A2CYP2D6GBA1CNR1
SCHEMBL945557 0.90 NCF1 (0.45) NCF1GBA1CNR1RAD52GNAO1
SCHEMBL2957778 0.89 CHRM5 (0.41) CYP2D6GBA1CNR1RAD52GNAO1
SCHEMBL151422 0.89 CHRM5 (0.41) CYP2D6GBA1CNR1RAD52GNAO1
SCHEMBL24480857 0.89 ACHE (0.40) NCF1GBA1CNR1RAD52GNAO1
SCHEMBL25026639 0.88 NCF1 (0.43) NCF1GBA1RAD52GNAO1POLB
SCHEMBL19782068 0.88 POLB (0.38) GBA1CNR1RAD52GNAO1POLB
SCHEMBL25026644 0.85 GNAO1 (0.49) NCF1CYP1A2CYP2D6GBA1GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023083194-A1 WEE1 PROTEIN KINASE DEGRADATION AGENT AND USE THEREOF 杭州格博生物医药有限公司 2023-05-19 WO disclosed
WO-2023023255-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF NURIX THERAPEUTICS, INC. (US) 2023-02-23 WO disclosed